10 ML rituximab-arrx 10 MG/ML Injection [Riabni]

RxCUI
2472332
RxNorm name
10 ML rituximab-arrx 10 MG/ML Injection [Riabni]
Display name
10 ML rituximab-arrx 10 MG/ML Injection [Riabni]
Full name
10 ML rituximab-arrx 10 MG/ML Injection [Riabni]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761140Riabnirituximab-arrx351(k) BiosimilarRx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RiabniRITUXIMAB-ARRXAmgen, Incda1c4de7-0e5b-4f72-97ec-7a8d368f085f2026-07-22Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2472332

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
da1c4de7-0e5b-4f72-97ec-7a8d368f085fRIABNI 100 MG in 10 ML Injection [PSN] · 10 ML rituximab-arrx 10 MG/ML Injection [Riabni] [SBD] · 10 ML Riabni 10 MG/ML Injection [SY] · Riabni 100 MG per 10 ML Injection [SY]49These highlights do not include all the information needed to use RIABNI safely and effectively. See full prescribing information for RIABNI. RIABNI ® (rituximab-arrx) injection, for intravenous use Initial U.S. Approval: 2020 RIABNI (rituximab-arrx) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences between the20250912